Important announcement concerning Temple Health and Keystone First. Our provider agreement with Keystone First, is scheduled to end on July 31st. Learn about your options to continue receiving care at Temple Health.
Fox Chase Cancer Center Welcomes Dr. Michelle Pedersen
PHILADELPHIA (July 22, 2024)—Fox Chase Cancer Center is pleased to announce the hiring of Michelle Pedersen, DO, as a hospitalist and Assistant Professor in the Division of Hospital Medicine within the Department of Medicine.
The hospitalists at Fox Chase help establish a bridge between highly specialized cancer care and general medicine. Their goal is to provide the highest quality medical care to patients receiving cancer care at Fox Chase.
Pedersen is joining Fox Chase following the completion of a Hospice and Palliative Medicine Fellowship at Fox Chase and Temple University Hospital. In the three years prior to that, she was a hospitalist in the Inpatient Oncology Unit at Reading Hospital in West Reading, Pennsylvania.
Pedersen earned her undergraduate degree in biology from Messiah University in Mechanicsburg, Pennsylvania. She earned her medical degree from the Edward Via College of Osteopathic Medicine in Blacksburg, Virginia. Pedersen initially trained in family medicine at the Lehigh Valley Health Network and then completed an internal medicine residency at Garden City Hospital in Michigan.
As part of her fellowship at Fox Chase, Pedersen worked on a quality improvement project with the goal of improving naloxone prescriptions for patients in outpatient supportive oncology and palliative care clinics. She also took part in a practice improvement project at Lehigh Valley Health Network aimed at improving the percentage of mammograms in outpatient offices. Her professional interests include social determinants of health, hematology and oncology, palliative care, and hospital medicine.
Over the course of her career, Pedersen was an author on multiple peer-reviewed articles in journals such as Nanomedicine and The American Journal of Physiology-Endocrinology and Metabolism and has lectured on a variety of topics at both Fox Chase and Garden City Hospital.
She is a member of the American College of Physicians, the American Osteopathic Association, the Pennsylvania Medical Society, and the American Academy of Hospice and Palliative Medicine.
Pedersen will begin her tenure at Fox Chase on July 22.
Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence six consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.
For more information, call 888-369-2427